The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections
| Status: | Archived |
|---|---|
| Conditions: | Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2010 |
| End Date: | December 2010 |
The Effects of Ethyl-alpha-Guanido-methyl Ethanoate on Skin Reactions Form Glatiramer Acetate
Participants are asked to be in this study because they have multiple sclerosis, are
currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain,
swelling, itching or a lump at the injection site.
The purpose of this study is to determine if the use of ethyl-a-guanida-methyl ethanoate
(AGEE) will decrease histamine response measured by redness, swelling, and itch response
following subcutaneous injection of glatiramer acetate (GA) for the treatment of Multiple
Sclerosis (MS).
We found this trial at
1
site
Click here to add this to my saved trials
